The Federal Circuit affirmed the PTAB’s finding that all 17 claims of Pictometry’s patent on measuring roofs from aerial imagery are unpatentable as obvious over prior art combining roof-measurement and marker-locking references.
An Eastern District of Texas jury awarded SK nexilis $3.3 million after finding that Solus Advanced Materials and its Volta Energy subsidiaries willfully infringed five patents covering electrolytic copper foil manufacturing methods used in electric vehicle batteries.
A federal court in the Southern District of California dismissed all claims from five ad-viewability and ad-refresh patents as patent-ineligible under Section 101, finding they recite abstract ideas of determining whether a webpage area is visible and sending content based on that determination.
A Central District of California judge denied motions to dismiss Disney, Universal, and Warner Bros.’ copyright claims against the makers of Hailuo AI, finding that the video-generation tool’s reproduction of iconic characters like Spider-Man and Darth Vader plausibly constitutes both di
A federal court in the Eastern District of Missouri denied cross-motions for summary judgment in a trade secret case where departing employees allegedly prepared requests for proposals for a competitor while still employed, sending the case to trial on misappropriation and fiduciary duty claims.
A federal magistrate in Kansas recommended adverse inference sanctions against OPISystems for spoliation of evidence in a trade secret case involving stolen agricultural grain-bin management source code, after finding that a former employee stored proprietary code on personal devices and a competito
A federal court in the Eastern District of California dismissed trademark infringement claims involving the ALIEN mark for nicotine products after the plaintiff failed, even on a second attempt, to adequately plead priority of use over the defendant’s ALIENLABS mark for cannabis products.
The Federal Circuit affirmed the PTAB’s finding that all claims of a synchronized-browsing patent were unpatentable as obvious, rejecting the patent holder’s bid to narrowly construe the key claim term “web browsing interaction data.”
The Federal Circuit affirmed that Lupin’s generic tolvaptan manufacturing process does not infringe Otsuka’s patents and that certain synthesis method claims are obvious, clearing the way for a generic version of the kidney disease drug JYNARQUE®.
A Delaware jury unanimously found that Cummins Inc. misappropriated C3 AI trade secrets and awarded $23.3 million in damages, adding to the growing body of high-value trade secret verdicts involving proprietary AI technology.